Pharmaceutical / Drug Definition :
May cause morphologic changes and DNA fragmentation in promyelocytic leukemia cells, causing cell death and degradation of or damage to PML/RAR alpha (a fusion protein).
FDA Label Requirements and Exceptions
FDA Import Information
Arsenic Trioxide (Arsenic Trioxide Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Arsenic Trioxide (Arsenic Trioxide Suppliers)
- Processors Arsenic Trioxide
- Repackers Arsenic Trioxide
- Relabelers Arsenic Trioxide
- Exporters Arsenic Trioxide
- Importers Arsenic Trioxide
For more information about Arsenic Trioxide, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.